FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ASNSD1-RPL3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ASNSD1-RPL3
FusionPDB ID: 7195
FusionGDB2.0 ID: 7195
HgeneTgene
Gene symbol

ASNSD1

RPL3

Gene ID

110599588

6122

Gene nameASNSD1 upstream reading frameribosomal protein L3
SynonymsASNSD1|ASNSD1-SEP|NS3TP1ASC-1|L3|TARBP-B
Cytomap

2q32

22q13.1

Type of geneprotein-codingprotein-coding
DescriptionASNSD1 upstream open reading frame proteinAsparagine synthetase domain-containing protein 1HCV NS3-transactivated protein 1alternative protein ASNSD160S ribosomal protein L3HIV-1 TAR RNA-binding protein Blarge ribosomal subunit protein uL3
Modification date2020030320200313
UniProtAcc

Q9NWL6

Main function of 5'-partner protein:
.
Ensembl transtripts involved in fusion geneENST idsENST00000607535, ENST00000607690, 
ENST00000607829, ENST00000260952, 
ENST00000607062, 
ENST00000401609, 
ENST00000465618, ENST00000216146, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score3 X 2 X 3=1815 X 13 X 7=1365
# samples 316
** MAII scorelog2(3/18*10)=0.736965594166206
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(16/1365*10)=-3.09275714091985
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ASNSD1 [Title/Abstract] AND RPL3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ASNSD1 [Title/Abstract] AND RPL3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ASNSD1(190526336)-RPL3(39710213), # samples:1
Anticipated loss of major functional domain due to fusion event.ASNSD1-RPL3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ASNSD1-RPL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:190526336/chr22:39710213)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ASNSD1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RPL3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000607535ASNSD1chr2190526336+ENST00000216146RPL3chr2239710213-57115247514155
ENST00000607690ASNSD1chr2190526336+ENST00000216146RPL3chr2239710213-509900452150
ENST00000607829ASNSD1chr2190526336+ENST00000216146RPL3chr2239710213-509900452150

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000607535ENST00000216146ASNSD1chr2190526336+RPL3chr2239710213-0.0039010690.9960989
ENST00000607690ENST00000216146ASNSD1chr2190526336+RPL3chr2239710213-0.0045913350.9954086
ENST00000607829ENST00000216146ASNSD1chr2190526336+RPL3chr2239710213-0.0045913350.9954086

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ASNSD1-RPL3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ASNSD1chr2190526336RPL3chr223971021315235DNSTPHKEDLSSKIYKIGQGYLIKDG
ASNSD1chr2190526336RPL3chr22397102139030DNSTPHKEDLSSKIYKIGQGYLIKDG

Top

Potential FusionNeoAntigen Information of ASNSD1-RPL3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ASNSD1-RPL3_190526336_39710213.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B39:13KEDLSSKI0.83450.6654614
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:03KEDLSSKIY0.9990.7666615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:01KIYKIGQGY0.9990.64811221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:25KIYKIGQGY0.99660.65351221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:02KIYKIGQGY0.99060.68051221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:01KEDLSSKIY0.98230.7493615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:17KIYKIGQGY0.97650.58231221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-A32:13KIYKIGQGY0.61840.70521221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:03KEDLSSKIY0.11050.5377615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:03HKEDLSSKIY0.4940.7633515
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:21KIYKIGQGY0.98880.58321221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:04KIYKIGQGY0.92660.64731221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:05KIYKIGQGY0.90230.55871221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:31KIYKIGQGY0.79710.57171221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C15:04KIYKIGQGY0.60310.65431221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:13KEDLSSKIY0.9990.7666615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:125KIYKIGQGY0.9990.64811221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:34KIYKIGQGY0.9990.64811221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:27KIYKIGQGY0.9990.69041221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:26KEDLSSKIY0.9990.7666615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:07KEDLSSKIY0.9990.7666615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:33KIYKIGQGY0.9990.64811221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:135KIYKIGQGY0.99890.68641221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:50KIYKIGQGY0.99850.5731221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:35KIYKIGQGY0.99690.54721221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:24KIYKIGQGY0.99570.65321221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:12KIYKIGQGY0.99540.51011221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:53KIYKIGQGY0.98630.59831221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:04KEDLSSKIY0.98610.7786615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:08KEDLSSKIY0.98420.6908615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:05KEDLSSKIY0.98230.7493615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:06KEDLSSKIY0.97810.7397615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:11KEDLSSKIY0.92480.689615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-A32:01KIYKIGQGY0.92330.66231221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:20KIYKIGQGY0.90190.66541221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-A30:01KIYKIGQGY0.88460.61891221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B35:28KIYKIGQGY0.84370.67981221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:54KIYKIGQGY0.77070.55581221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C15:09KIYKIGQGY0.60310.65431221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B35:28KEDLSSKIY0.53730.705615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C03:02KIYKIGQGY0.42980.8331221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B48:02KIYKIGQGY0.38090.64851221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C12:02KIYKIGQGY0.22890.80481221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:53KEDLSSKIY0.19330.6747615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B48:02KEDLSSKIY0.16730.6776615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C02:02KIYKIGQGY0.06930.83021221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-C02:10KIYKIGQGY0.06930.83021221
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:54KEDLSSKIY0.01380.6725615
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:27SKIYKIGQGY0.94280.54711121
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B15:135SKIYKIGQGY0.94060.56471121
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B18:11HKEDLSSKIY0.79110.7532515
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:13HKEDLSSKIY0.4940.7633515
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:07HKEDLSSKIY0.4940.7633515
ASNSD1-RPL3chr2190526336chr2239710213152HLA-B44:26HKEDLSSKIY0.4940.7633515

Top

Potential FusionNeoAntigen Information of ASNSD1-RPL3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ASNSD1-RPL3_190526336_39710213.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0101SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0101SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0103SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0103SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0105SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0105SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0107SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0107SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0109SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0109SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0111SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0111SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0113SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0113SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0115SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0115SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0117SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0117SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0119SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0119SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0121SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0121SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0125SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0125SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0127SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0127SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0129SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0129SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0131SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0131SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0701SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0703SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0704SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0704SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0704LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0705SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0706SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0706SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0707SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0708SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0709SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0709SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0711SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0711SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0712SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0713SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0714SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0715SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0716SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0717SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0719SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0901SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0901SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0901LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0902SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0902SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0903SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0903SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0904SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0904SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0904LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0905SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0905SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0905LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0907SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0907SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0907LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0908SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0908SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0909SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0909SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-0909LSSKIYKIGQGYLIK924
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1511SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1511SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1515SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1527SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1527SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1529SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1531SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1534SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1534SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1601SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1601SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1602SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1602SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1603SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1603SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1604SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1604SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1605SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1605SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1607SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1607SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1608SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1608SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1609SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1610SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1610SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1611SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1611SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1612SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1612SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1614SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1614SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1616SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB1-1616SSKIYKIGQGYLIKD1025
ASNSD1-RPL3chr2190526336chr2239710213152DRB5-0112SKIYKIGQGYLIKDG1126
ASNSD1-RPL3chr2190526336chr2239710213152DRB5-0112SSKIYKIGQGYLIKD1025

Top

Fusion breakpoint peptide structures of ASNSD1-RPL3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4176KEDLSSKIYKIGQGASNSD1RPL3chr2190526336chr2239710213152

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ASNSD1-RPL3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4176KEDLSSKIYKIGQG-6.77781-6.89121
HLA-B14:023BVN4176KEDLSSKIYKIGQG-3.08719-4.12249
HLA-B52:013W394176KEDLSSKIYKIGQG-6.66315-6.77655
HLA-B52:013W394176KEDLSSKIYKIGQG-2.65785-3.69315
HLA-A24:025HGA4176KEDLSSKIYKIGQG-7.20627-7.31967
HLA-A24:025HGA4176KEDLSSKIYKIGQG-6.50211-7.53741
HLA-B44:053DX84176KEDLSSKIYKIGQG-7.75024-7.86364
HLA-B44:053DX84176KEDLSSKIYKIGQG-6.53073-7.56603
HLA-A02:016TDR4176KEDLSSKIYKIGQG-4.4528-5.4881

Top

Vaccine Design for the FusionNeoAntigens of ASNSD1-RPL3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ASNSD1-RPL3chr2190526336chr22397102131121SKIYKIGQGYAGCAAGATTTATAAGATTGGCCAGGGCTAC
ASNSD1-RPL3chr2190526336chr22397102131221KIYKIGQGYAAGATTTATAAGATTGGCCAGGGCTAC
ASNSD1-RPL3chr2190526336chr2239710213515HKEDLSSKIYCACAAGGAGGATCTAAGCAGCAAGATTTAT
ASNSD1-RPL3chr2190526336chr2239710213614KEDLSSKIAAGGAGGATCTAAGCAGCAAGATT
ASNSD1-RPL3chr2190526336chr2239710213615KEDLSSKIYAAGGAGGATCTAAGCAGCAAGATTTAT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ASNSD1-RPL3chr2190526336chr22397102131025SSKIYKIGQGYLIKDAGCAGCAAGATTTATAAGATTGGCCAGGGCTACCTTATCAAGGAC
ASNSD1-RPL3chr2190526336chr22397102131126SKIYKIGQGYLIKDGAGCAAGATTTATAAGATTGGCCAGGGCTACCTTATCAAGGACGGC
ASNSD1-RPL3chr2190526336chr2239710213924LSSKIYKIGQGYLIKCTAAGCAGCAAGATTTATAAGATTGGCCAGGGCTACCTTATCAAG

Top

Information of the samples that have these potential fusion neoantigens of ASNSD1-RPL3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADASNSD1-RPL3chr2190526336ENST00000607535chr2239710213ENST00000216146TCGA-HU-A4HB-01A

Top

Potential target of CAR-T therapy development for ASNSD1-RPL3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ASNSD1-RPL3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ASNSD1-RPL3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource